Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
Xiao Y, Lidsky PV, Shirogane Y, Aviner R, Wu CT, Li W, Zheng W, Talbot D, Catching A, Doitsh G, Su W, Gekko CE, Nayak A, Ernst JD, Brodsky L, Brodsky E, Rousseau E, Capponi S, Bianco S, Nakamura R, Jackson PK, Frydman J, Andino R. Xiao Y, et al. Among authors: talbot d. Cell. 2021 Dec 9;184(25):6037-6051.e14. doi: 10.1016/j.cell.2021.11.023. Epub 2021 Nov 18. Cell. 2021. PMID: 34852237 Free PMC article.
Quantitative genetic-interaction mapping in mammalian cells.
Roguev A, Talbot D, Negri GL, Shales M, Cagney G, Bandyopadhyay S, Panning B, Krogan NJ. Roguev A, et al. Among authors: talbot d. Nat Methods. 2013 May;10(5):432-7. doi: 10.1038/nmeth.2398. Epub 2013 Feb 13. Nat Methods. 2013. PMID: 23407553 Free PMC article.
Reply to Zeng and Zhou.
Djade CD, Diorio C, Laurin D, Talbot D, Carmichael PH, Dionne CE. Djade CD, et al. Among authors: talbot d. Pain. 2025 Apr 15;166(7):1708-1709. doi: 10.1097/j.pain.0000000000003610. Pain. 2025. PMID: 40532076 No abstract available.
Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-19 hospitalization in Quebec, Canada: Impact of variant replacement and waning protection during 10-month follow-up.
Carazo S, Skowronski DM, Brousseau N, Guay CA, Sauvageau C, Racine É, Talbot D, Ionescu IG, Fafard J, Gilca R, Phimmasone J, De Wals P, De Serres G. Carazo S, et al. Among authors: talbot d. PLoS One. 2025 Jun 3;20(6):e0325269. doi: 10.1371/journal.pone.0325269. eCollection 2025. PLoS One. 2025. PMID: 40460407 Free PMC article.
Symptom burden in myeloproliferative neoplasms: clinical correlates, dynamics, and survival impact-a study of 784 patients from the Quebec MPN research group.
Poullet A, Busque L, Sirhan S, Delage R, Cournoyer G, Chamakhi I, Talbot D, Mollica L, Marceau D, Ethier V, Desjardins P, Olney HJ, Harnois M, Szuber N. Poullet A, et al. Among authors: talbot d. Blood Cancer J. 2025 Apr 1;15(1):51. doi: 10.1038/s41408-025-01234-8. Blood Cancer J. 2025. PMID: 40169545 Free PMC article. No abstract available.
Switching TKIs during CML therapy is frequent, mostly driven by intolerance, and does not affect survival: a prospective Quebec registry study.
Busque L, Beaudet MÉ, Harnois M, Moussa H, Szuber N, Mollica L, Delage R, Olney H, Laneuville P, Cournoyer G, Chamakhi I, Lalancette M, Talbot D, Ethier V, Desjardins P, Assouline S. Busque L, et al. Among authors: talbot d. Blood Cancer J. 2025 Mar 11;15(1):35. doi: 10.1038/s41408-025-01242-8. Blood Cancer J. 2025. PMID: 40069191 Free PMC article.
651 results